Hjem › Blodcancer › Minnesota
Blodcancer kliniske forsøg i Minnesota
17 studier for Blodcancer søger deltagere på steder i Minnesota.
Byer i Minnesota
Officiel studietekst (engelsk)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- og 48 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Sanford Joe Lueken Cancer Center, Bemidji
- Minnesota Oncology - Burnsville, Burnsville
- Mercy Hospital, Coon Rapids
- og 24 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. sep. 2026 · NCT04242095Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Mayo Clinic, Rochester
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT04588922Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Minnesota, Minneapolis
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT07007312PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- University of Minnesota, Minneapolis
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT06665100Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- Masonic Cancer Center, University of Minnesota, Minneapolis
Rekrutterer
Alle aldre · Alle køn · Opdateret 8. maj 2026 · NCT01451502CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Mayo Clinic, Rochester
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT03328078MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- University of Minnesota Masonic Cancer Center, Minneapolis
RekruttererFase 2
Op til 60 år · Alle køn · Opdateret 6. apr. 2026 · NCT05735717Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
- Mayo Clinic, Rochester
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 1. apr. 2026 · NCT02457962Avera Cancer Sequencing and Analytics Protocol (ASAP)
- Avera Cancer Institute - Marshall, Marshall
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 27. mar. 2026 · NCT05142033Role of Gut Microbiome in Cancer Therapy
- Mayo Clinic in Rochester, Rochester
RekruttererObservationsstudie
Alder 18 til 99 · Alle køn · Opdateret 16. mar. 2026 · NCT05112614A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- University of Minnesota, Minneapolis
- Mayo Clinic - Rochester, Rochester
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 13. mar. 2026 · NCT05735184Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
- Mayo Clinic in Rochester, Rochester
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 23. feb. 2026 · NCT02958462CIBMTR Research Database
- Center for International Blood and Marrow Transplant Research, Minneapolis
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 12. aug. 2025 · NCT01166009IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
- University of Minnesota, Minneapolis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 3. jun. 2025 · NCT06119685Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- University of Minnesota, Minneapolis
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. apr. 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital and Clinics of Minnesota, Minneapolis
RekruttererFase 1
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.